|The LMAN2/VIP36 n/a (Catalog #MBS2543709) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse anti Human LMAN2/VIP36 Monoclonal Antibody reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s LMAN2/VIP36 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA), Immunoprecipitation (IP).
WB: 5-10 mug/mL
ELISA: 0.5-1 mug/mL. This antibody can be used at 0.5-1 mug/mL with the appropriate secondary reagents to detect Human LMAN2. The detection limit for Human LMAN2 is approximately 0.078 ng/well.
IP: 4-6 mug/mg of lysate. Researchers should empirically determine the suitability of the LMAN2/VIP36 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The LMAN2/VIP36 n/a product has the following accession number(s) (GI #958199037). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Recombinant Human LMAN2/VIP36 protein
Buffer: 0.2 mum filtered solution in PBS with 5% trehalose. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing LMAN2/VIP36 are readily searchable from our website. Different antibodies against the same target such as LMAN2/VIP36 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.